Based on these findings and in view of more recent publications, revealing A20 as a negative parameter on the outcome of breast cancer patients [21], results of the present cohort study certainly require a deeper insight in possible underlying mechanisms. This evidence concerns the gene TNFAIP3 and breast cancer.